It is a information technology foreign private limited company based in Bangalore South, Karnataka, India, established in 2023.
2023 | Bangalore South, Karnataka, India | ActiveCresset Biomolecular Discovery (India) Private Limited, a active foreign private limited company, was established on 29 December 2023 in Bangalore South, Karnataka, India. Engaging in application development & software solutions within the information technology sector, it holds CIN: U62013KA2023FTC182898. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes John Perrot Leighton (Director), Krishna Kumar Muraleedharan (Director). Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at Prestige Atlanta No.10,80Ft Road,3Rd Block, Koramangala, Bangalore, Bangalore South, Karnataka, 560034.
U62013KA2023FTC182898
182898
29 December 2023
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Cresset Biomolecular Discovery (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| John Perrot Leighton | Director | 29 Dec 2023 | Current |
| Krishna Kumar Muraleedharan | Director | 29 Dec 2023 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Cresset Biomolecular Discovery (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Cresset Biomolecular Discovery (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Cresset Biomolecular Discovery (India) has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cresset Biomolecular Discovery (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cresset Biomolecular Discovery (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cresset Biomolecular Discovery (India) Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was recorded as a recent event.
Progress on Cresset Biomolecular Discovery (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity John Perrot Leighton was appointed as a Director was appointed as a Director on 29 Dec 2023 & has been associated with this company since 1 year 11 months . was completed.
Krishna Kumar Muraleedharan was appointed as a Director was appointed as a Director on 29 Dec 2023 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
Progress on Cresset Biomolecular Discovery (India) Private Limited was registered on 29 Dec 2023 with Roc Bangalore & aged 1 year 11 months as per MCA records. was documented.
The CIN of Cresset Biomolecular Discovery (India) Private Limited is U62013KA2023FTC182898.
Cresset Biomolecular Discovery (India) Private Limited is headquartered at Prestige Atlanta No.10,80Ft Road,3Rd Block, Koramangala, Bangalore, Bangalore South, Karnataka, 560034.
Cresset Biomolecular Discovery (India) Private Limited was incorporated on 29 December 2023.
The current directors of Cresset Biomolecular Discovery (India) Private Limited are
The primary industry of Cresset Biomolecular Discovery (India) Private Limited is Information Technology.
Cresset Biomolecular Discovery (India) Private Limited is unlisted.
The authorized capital of Cresset Biomolecular Discovery (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX